Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization

Biomolecules
Athina AndreaHåvard Jenssen

Abstract

Bacterial biofilms pose a major threat to public health, as they are associated with at least two thirds of all infections. They are highly resilient and render conventional antibiotics inefficient. As a part of the innate immune system, antimicrobial peptides have drawn attention within the last decades, as some of them are able to eradicate biofilms at sub-minimum inhibitory concentration (MIC) levels. However, peptides possess a number of disadvantages, such as susceptibility to proteolytic degradation, pH and/or salinity-dependent activity and loss of activity due to binding to serum proteins. Hence, proteolytically stable peptidomimetics were designed to overcome these drawbacks. This paper summarizes the current peptide and peptidomimetic strategies for combating bacteria-associated biofilm infections, both in respect to soluble and surface-functionalized solutions.

References

Feb 1, 1977·Quarterly Reviews of Biophysics·G Ehrenstein, H Lecar
Mar 1, 1996·Journal of Biomedical Materials Research·J S PriceG A Bohach
Jan 26, 1999·JAMA : the Journal of the American Medical Association·D L VeenstraS D Sullivan
May 21, 1999·Science·J W CostertonE P Greenberg
Mar 18, 2000·The Journal of Infectious Diseases·J J BoelensS A Zaat
Apr 14, 2000·The Journal of Infectious Diseases·J J BoelensS A Zaat
Jul 6, 2000·Drugs·K Kanellakopoulou, E J Giamarellos-Bourboulis
Sep 7, 2000·Microbiology and Molecular Biology Reviews : MMBR·K Lewis
Sep 16, 2000·Trends in Microbiology·R E Hancock, G Diamond
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·K Lewis
Mar 22, 2001·Biochemistry·J H Waite, X Qin
Jun 23, 2001·Biosensors & Bioelectronics·J PiehlerG Gauglitz
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Clay Fuqua, E Peter Greenberg
Mar 5, 2003·Pharmacological Reviews·Michael R Yeaman, Nannette Y Yount
Apr 3, 2003·Journal of the American Chemical Society·Jeffrey L DalsinPhillip B Messersmith
Sep 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michiko E Taga, Bonnie L Bassler
Sep 3, 2003·Biomaterials·Arpan SatsangiJoo L Ong
Nov 20, 2003·Journal of the American Chemical Society·Ken-Ichi Sano, Kiyotaka Shiba
Jan 23, 2004·Chemical Society Reviews·Steve EdmondsonWilhelm T S Huck
Sep 3, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·M StigterP Layrolle
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Magdalena Sieprawska-LupaJan Potempa
Jan 12, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Jeffrey L DalsinPhillip B Messersmith
Jun 2, 2005·Journal of the American Chemical Society·Andrea R StatzPhillip B Messersmith
Nov 22, 2005·Infectious Disease Clinics of North America·Irene G SiaAdolf W Karchmer
Dec 21, 2005·Biomaterials·Davide CampocciaCarla Renata Arciola
Mar 9, 2006·Nano Letters·Tomohiro HayashiMasahiko Hara
Mar 16, 2006·Bioconjugate Chemistry·Matthias GabrielAndrej Zentner
Apr 8, 2006·Journal of Biomedical Materials Research. Part a·Seunghan OhSungho Jin
Jun 23, 2006·Drugs·Andrej Trampuz, Werner Zimmerli
Aug 8, 2006·Current Opinion in Pharmacology·Alexandra K MarrRobert Ew Hancock
Aug 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Haeshin LeePhillip B Messersmith
Feb 27, 2007·Journal of Materials Science. Materials in Medicine·R WillumeitF Feyerabend
Mar 16, 2007·Implant Dentistry·Joel D BumgardnerJoo L Ong
Jul 10, 2007·Current Opinion in Biotechnology·François Baneyx, Daniel T Schwartz
Sep 14, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·R NarayananK H Kim
Oct 20, 2007·Science·Haeshin LeePhillip B Messersmith
Feb 14, 2008·Journal of Clinical Periodontology·Cristiano SusinUlf M E Wikesjö
Jul 2, 2008·Infection and Immunity·Joerg OverhageRobert E W Hancock
Jul 23, 2008·Journal of Biomaterials Science. Polymer Edition·Ross P CarlsonPhilip S Stewart
Aug 9, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Meital Zilberman, Jonathan J Elsner
Aug 13, 2008·Biofouling·Andrea R StatzPhillip B Messersmith
Sep 10, 2008·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Cornelius von WilmowskyKarl Andreas Schlegel
Nov 20, 2008·Journal of Applied Microbiology·M D P WillcoxN Cole
Nov 26, 2008·Biochimica Et Biophysica Acta·Shahar Rotem, Amram Mor

❮ Previous
Next ❯

Citations

Feb 15, 2020·Chemistry : a European Journal·Abshar HasanKing Hang Aaron Lau
Sep 23, 2020·Chemical Communications : Chem Comm·Hadar CherikerZvi Hayouka
Oct 3, 2018·Frontiers in Microbiology·Rafael Gomes Von BorowskiReynald Gillet
Jan 11, 2020·Frontiers in Microbiology·Nigare Raheem, Suzana K Straus
Apr 30, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Éric PardouxYoann Roupioz
Oct 20, 2020·Critical Reviews in Biotechnology·Mehdi Kazemzadeh-NarbatAli Khademhosseini
Aug 25, 2019·Biochemical and Biophysical Research Communications·Deepika SharmaGopal Singh Bisht
Mar 5, 2019·Accounts of Chemical Research·John S Mjøen SvendsenJohan Svenson

❮ Previous
Next ❯

Methods Mentioned

BETA
lipidation

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved